You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Details for Patent: 10,370,406


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,370,406
Title:Salts and polymorphs of SCY-078
Abstract: SCY-078 is a glucan synthase inhibitor with antimicrobial activity. Novel salts and polymorph forms of SCY-078 are disclosed herein. The disclosure also relates to pharmaceutical compositions, methods of use, and methods of preparing the novel salts and polymorphs of SCY-078.
Inventor(s): Zhang; Yi (Suzhou, CN)
Assignee: SCYNEXIS, INC. (Jersey City, NJ)
Application Number:16/203,273
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,370,406

To conduct a detailed analysis of the scope and claims of a specific patent, such as United States Patent 10,370,406, it is essential to delve into several key areas, including the patent's claims, the prior art, the obviousness standard, patent eligibility, and the broader patent landscape.

Understanding Patent Claims

Claim Structure and Scope

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent. The claims in a patent like 10,370,406 would be categorized into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

Claim Coverage Matrix

A Claim Coverage Matrix can be used to analyze which patents and claims are actively protecting the intellectual property related to the invention. This matrix helps in identifying gaps or opportunities in the patent coverage and can be particularly useful for managing a large portfolio of patents[3].

Prior Art and Obviousness

Obviousness Standard

The obviousness standard, as outlined in 35 U.S.C. § 103, determines whether the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious to a person having ordinary skill in the art (PHOSITA) before the effective filing date of the claimed invention. The Supreme Court decisions in Graham v. John Deere Co. and KSR Int'l Co. v. Teleflex Inc. have shaped this standard, emphasizing the scope and content of the prior art, the differences between the prior art and the claimed invention, and secondary considerations such as commercial success and long-felt but unsolved needs[1].

Teaching, Suggestion, or Motivation (TSM) Test

Although the TSM test, which required a teaching, suggestion, or motivation in the prior art to combine elements, was rejected by the Supreme Court in KSR Int'l Co. v. Teleflex Inc., it still influences how courts assess obviousness. The KSR decision emphasized that common sense and the knowledge of a PHOSITA can direct the combination of prior art elements even without explicit motivation in the prior art[1].

Patent Eligibility

Section 101 of the Patent Act

To be patentable, an invention must fall within one of the four categories outlined in Section 101 of the Patent Act: processes, machines, manufactures, or compositions of matter. Recent Supreme Court decisions, such as Bilski v. Kappos, Mayo Collaborative Servs. v. Prometheus Labs., and Alice Corp. v. CLS Bank Int'l, have narrowed the scope of patent-eligible subject matter by broadening the judicially developed exceptions to include abstract ideas, laws of nature, and natural phenomena[5].

Alice/Mayo Test

The Alice/Mayo test is a two-step framework used to determine patent eligibility. First, it is determined whether the claims are directed to an ineligible concept. If they are, the second step assesses whether the claims contain an inventive concept that transforms the ineligible concept into something patentable[5].

Patent Landscape Analysis

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can be used to analyze trends in patent scope and claim-level statistics, helping to understand the broader patent landscape and how a specific patent like 10,370,406 fits within it[2].

Claim Charts and Scope Concepts

Using tools like ClaimScape® software, claim charts can be generated to review patent coverage. These charts help in identifying whether a particular scope concept is applicable to a target product or method, highlighting gaps in current coverage and future design opportunities. This approach categorizes patents by claims and overarching scope concepts, making it easier to analyze large numbers of patent claims concurrently[3].

Case Study: Healthcare Data Analytics Patent

Covered Business Method (CBM) Review

A patent like the one described in the healthcare data analytics example, which involves de-identifying health care records and generating reports for business decisions, could be subject to Covered Business Method (CBM) review. This review assesses whether the patent claims activities used in the practice, administration, or management of a financial product or service, which can impact its validity and scope[4].

Key Considerations for Patent 10,370,406

Claim Specificity

To ensure the patent's claims are robust, it is crucial to analyze their specificity and breadth. Overly broad claims may face challenges under the obviousness standard or patent eligibility tests, while overly narrow claims may not provide sufficient protection.

Prior Art Analysis

A thorough analysis of the prior art is essential to determine whether the claimed invention would have been obvious to a PHOSITA. This involves examining the scope and content of the prior art, the differences between the prior art and the claimed invention, and any secondary considerations.

Market and Competitive Landscape

Understanding the market and competitive landscape can help in identifying gaps and opportunities in the patent coverage. This includes analyzing competitors' patents and identifying areas where the patent in question provides unique protection.

Tools and Methods for Analysis

Patent Analytics Software

Utilizing patent analytics software, such as ClaimScape®, can streamline the analysis process by categorizing patents by claims and scope concepts. This helps in filtering, searching, and accurately analyzing large numbers of patent claims.

Claim Charts and Coverage Matrices

Generating claim charts and using claim coverage matrices are effective methods for reviewing patent coverage and identifying areas where the patent provides protection and where gaps exist.

Key Takeaways

  • Patent Claims: The claims define the scope of the invention and must be carefully crafted to ensure robust protection.
  • Obviousness Standard: The differences between the claimed invention and the prior art must be assessed to determine obviousness.
  • Patent Eligibility: The invention must fall within one of the four categories outlined in Section 101 of the Patent Act and pass the Alice/Mayo test.
  • Patent Landscape Analysis: Analyzing the broader patent landscape using datasets and analytics tools helps in understanding the patent's position and identifying opportunities and gaps.
  • Market and Competitive Analysis: Understanding the market and competitive landscape is crucial for maximizing the patent's value.

Frequently Asked Questions (FAQs)

Q: What is the importance of claim specificity in a patent?

A: Claim specificity is crucial because overly broad claims may face challenges under the obviousness standard or patent eligibility tests, while overly narrow claims may not provide sufficient protection.

Q: How does the KSR decision impact obviousness determinations?

A: The KSR decision emphasized that common sense and the knowledge of a PHOSITA can direct the combination of prior art elements even without explicit motivation in the prior art.

Q: What is the Alice/Mayo test, and how is it applied?

A: The Alice/Mayo test is a two-step framework used to determine patent eligibility. It first determines whether the claims are directed to an ineligible concept and then assesses whether the claims contain an inventive concept that transforms the ineligible concept into something patentable.

Q: How can patent analytics software aid in patent landscape analysis?

A: Patent analytics software can categorize patents by claims and scope concepts, making it easier to filter, search, and accurately analyze large numbers of patent claims concurrently.

Q: What is the purpose of a Claim Coverage Matrix?

A: A Claim Coverage Matrix shows which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist, helping to identify areas where the patent coverage is insufficient.

Cited Sources:

  1. Gao, Y. (2016-2017). Lead Compound Analysis for Chemicals: Obvious or Nonobvious? [PDF]. Michigan State University College of Law.
  2. USPTO. (2017). Patent Claims Research Dataset. USPTO Economic Research.
  3. Schwegman, Lundberg & Woessner, P.A. Patent Analytics. SLWIP.
  4. Holland & Knight LLP. (2015). Healthcare Data Analytics Patent Subject to “CBM” Review at USPTO. Holland & Knight LLP.
  5. Congressional Research Service. (2024). Patent-Eligible Subject Matter Reform: An Overview. CRS Reports.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,370,406

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Scynexis BREXAFEMME ibrexafungerp citrate TABLET;ORAL 214900-001 Jun 1, 2021 RX Yes Yes 10,370,406 ⤷  Try for Free TREATMENT OF ADULT AND POST-MENARCHAL PEDIATRIC FEMALES WITH VULVOVAGINAL CANDIDIASIS (VVC) ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,370,406

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus 1125272 ⤷  Try for Free
Denmark 3247711 ⤷  Try for Free
Eurasian Patent Organization 036874 ⤷  Try for Free
Eurasian Patent Organization 201791645 ⤷  Try for Free
European Patent Office 3247711 ⤷  Try for Free
European Patent Office 4039684 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.